- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 233/60 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
Patent holdings for IPC class C07D 233/60
Total number of patents in this class: 412
10-year publication summary
42
|
30
|
21
|
27
|
23
|
27
|
23
|
30
|
17
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 19740 |
19 |
Antecip Bioventures II LLC | 300 |
16 |
Tokyo Ohka Kogyo Co., Ltd. | 1481 |
10 |
Cellix Bio Private Limited | 67 |
7 |
Daicel Corporation | 2128 |
7 |
The University of British Columbia | 1432 |
7 |
vTv Therapeutics LLC | 159 |
6 |
Novartis AG | 11238 |
5 |
FUJIFILM Corporation | 27102 |
5 |
Agency for Science, Technology and Research | 3512 |
5 |
British Columbia Cancer Agency Branch | 195 |
5 |
Kureha Corporation | 1026 |
5 |
LG Energy Solution, Ltd. | 10813 |
5 |
Hoffmann-La Roche Inc. | 3060 |
4 |
Sumitomo Chemical Company, Limited | 8808 |
4 |
Henkel AG & Co. KGaA | 10129 |
4 |
Mitobridge, Inc. | 58 |
4 |
UDC Ireland Limited | 496 |
4 |
The United States Government AS represented by The Department of Veterans Affairs | 949 |
4 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
4 |
Other owners | 282 |